the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
September 16, 2022 – Beta thalassemias (β thalassemias) are a group of inherited blood disorders. They are forms of thalassemia caused by reduced or absent synthesis of the beta chains of hemoglobin that result in variable outcomes ranging from severe anemia …
Gene therapy: Hope for patients with beta-thalassemia? Read more »
April 22, 2014 – The U.S. Food and Drug Administration has just approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the region where the esophagus joins the stomach. …
FDA approves Ramucirumab [Cyramza] for stomach cancer Read more »